Only through Arjil, better life could be true.
One Arjil product a day keeps the Day great!
專注研發小分子藥品
帶給人們健康大未來 美好生活從吉亞展開
ARJIL Pharmaceuticals LLC 成立於 2014 年，是一家處於開發階段的專業製藥公司，專注於開發和商業化創新醫療產品。自成立以來，Arjil 一直致力於不斷探索、開發並提供以植物來源為基礎的藥物，旨在為全球老年人帶來健康福祉。截至 2024 年，Arjil 的資金投入已逾 2.5 億元台幣。
研發服務
Research and Development
我們致力於研發滿足未被滿足的醫療需求的藥物，並提升生活品質相關的產品，包括生物活性植物美容成分、源自植物藥物的健康食品，以及延緩衰老、提升老年人生活質量的抗老化產品。
We are committed to developing medicines for unmet medical needs and improving quality life products, including bioactive botanical cosmetic ingredients, healthy foods derived from botanical drugs, and anti-aging products for improving and extending quality of life for elderly people.
研究能量
ARJIL Strength
吳郁彬 董事長
在既有的組織架構下，我們已建立 QMS （質量管理系統），並結合新藥臨床試驗（ IND）流程，全面推動並加速藥物研發。我們採用數據驅動和風險管理的評估方式，穩步向著可預測的成功軌跡邁進。
With the QMS (Quality Management System) having been established on our organization infrastructure along the IND process, we have been holistically approaching and accelerating our drug R&D in data driven & risk managed (assessed) manners, and consistently moving toward a successful track in a predictable way.
在美國行醫近40年退休後投入生技醫藥產業
美國紐約大學 Bellevue Hospital 美國紐澤西
建立疼痛及麻醉臨床中心
美國紐澤西 Zeitech Corp 董事長
美國芝加哥 Arch Venture Fund
美國紐澤西 TBS Pharmaceutical Company 董事
美國紐澤西 Barjil Investment Group 總裁
Dr. James Sheu
Chief Science Officer
Ph.D., Department of Chemistry, University of Connecticut
Head of Medicines Division at the Biomedical Technology and Device Research Laboratories, ITRI
Director of the Material and Chemical Research Laboratories, ITRI
Richard Wu
MD
medical adviser Emergency Care and Thoracic Specialty Columbia University
Dr. Jane SC Tsai
Honorary Consultant U.S.A. SVP(Senior Vice President) International Affairs, YFY Biotech Management CompanySenior Advisor, Former Deputy General Director and COO(Chief Operating Officer), CTO(Chief Technology Officer), ITRI Roche Former Director,
Julian Yu
Chief Financial Officer
BS. EMBA , Department of Finance, National Taiwan University Director, Audit Division, Financial Department, Council of Economic Planning and Development Director, Risk Management Department, Laber Pension Fund Supersivise Committee Director, Domestic Investment Management Department, Bureau of Laber Pension Fund
Dr. Ming-Kun Chen
Manager
Postdoc. National Chung Hsing University PhD, Biotechnology, NCHU
Hui-Ju Liang
Product Manager
Biomedical Technology and Device Research Laboratories, ITRI Natural product isolation NTOU, Master